These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 166716)

  • 1. The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
    Altier H; Moldes M; Monti JM
    Br J Pharmacol; 1975 May; 54(1):101-6. PubMed ID: 166716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
    Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of monoamine oxidase inhibitors with a broad range of action on the structure and phase ratio of the wakefulness-sleep cycle in the cat].
    Akhvlediana GR; Oniani TN; Gvasalian MG
    Neirofiziologiia; 1988; 20(4):463-70. PubMed ID: 3200352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated administrations of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
    Susić V; Masirević G
    Gerontology; 1981; 27(1-2):1-6. PubMed ID: 7215813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleeping with and without norepinephrine: effects of metoclopramide and D,L-threo-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency.
    Tulen JH; Man in 't Veld AJ; Dzoljic MR; Mechelse K; Moleman P
    Sleep; 1991 Feb; 14(1):32-8. PubMed ID: 1811317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats.
    Unno K; Ozaki T; Mohammad S; Tsuno S; Ikeda-Sagara M; Honda K; Ikeda M
    Eur J Pharmacol; 2012 May; 683(1-3):179-85. PubMed ID: 22449385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electroencephalographical studies on the actions of hypnotic agents. 1. Effects of various hypnotic agents on the sleep and wakefulness cycle in the rabbit].
    Kimura K
    Nihon Yakurigaku Zasshi; 1973 Jul; 69(4):599-619. PubMed ID: 4365694
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25).
    Depoortere H; Loew DM
    Br J Pharmacol; 1971 Feb; 41(2):402P-403P. PubMed ID: 4324596
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I; Inagaki C; Araki H; Tanaka C
    Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of the sleep-wake cycle by heroin self-administration in rats.
    Coffey AA; Guan Z; Grigson PS; Fang J
    Brain Res Bull; 2016 May; 123():33-46. PubMed ID: 26431774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vigabatrin on sleep-wakefulness cycle in amygdala-kindled rats.
    Raol YH; Meti BL
    Epilepsia; 2000 Feb; 41(2):128-31. PubMed ID: 10691108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.
    Scheller D; Dürmüller N; Moser P; Porsolt RD
    Eur J Pharmacol; 2008 Apr; 584(1):111-7. PubMed ID: 18304531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of L-dopa.
    Bergonzi P; Chiurulla C; Cianchetti C; Tempesta E
    Confin Neurol; 1974; 36(1):5-22. PubMed ID: 4363375
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers.
    Gillin JC; Lardon M; Ruiz C; Golshan S; Salin-Pascual R
    J Clin Psychopharmacol; 1994 Aug; 14(4):264-7. PubMed ID: 7962682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of loxapine on the sleep-wakefulness cycle of the rat.
    Schmidek WR; Timo-Iaria C; Schmidek M; Krakowiak M; Delmutti EE; Alves MR
    Pharmacol Biochem Behav; 1974; 2(6):747-51. PubMed ID: 4377026
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits.
    Fujimori M; Himwich HE
    Physiol Behav; 1973 Sep; 11(3):291-5. PubMed ID: 4355439
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
    Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
    Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.